Complete CEAP classification (E, A, P components) and Venous Clinical Severity Score (VCSS)

in Chronic Venous Insufficiency and Varicose Veins

Applied

Type

Reinforcement

Confidence

75%

Created

Mar 19, 2026

Evidence

1 source

Rationale

The integration of the JURY study (Vemuri 2023) provides specific clinical validation for the VCSS, demonstrating its relationship with anatomical findings such as junctional reflux. This reinforces the existing text's claim regarding the score's utility for objective assessment. Additionally, all major abbreviations (CEAP, GSV, SSV, VCSS) were expanded on first use to comply with the required formatting standards.

Content Changes

<!-- type: classification -->

The complete CEAPClinical, Etiological, Anatomical, and Pathophysiological (CEAP) classification system extends beyond the clinical C0–C6 scale to include three additional descriptors that provide comprehensive characterization of venous disease:

**Etiology (E):**
* Ec: congenital venous disorders
* Ep: primary venous insufficiency
* Es: secondary (post-thrombotic) venous disease
* En: no identifiable venous cause

**Anatomy (A):**
* As: superficial veins (GSV,(great SSV,saphenous vein (GSV), small saphenous vein (SSV), and tributaries)
* Ap: perforator veins
* Ad: deep veins (femoral, popliteal, iliac)
* An: no venous anatomic location identified

**Pathophysiology (P):**
* Pr: reflux
* Po: obstruction
* Pr,o: combined reflux and obstruction
* Pn: no identifiable venous pathophysiology

Each classification includes a symptomatic (S) or asymptomatic (A) suffix. A complete CEAP designation might read: "C2, Ep, As, Pr, S" (symptomatic varicose veins from primary superficial venous reflux).

**Venous Clinical Severity Score (VCSS):**

The VCSSVenous Clinical Severity Score (VCSS) complements CEAP by providing a quantitative severity assessment. This 10-item instrument scores pain, varicose veins, edema, pigmentation, inflammation, induration, number of active ulcers, ulcer duration, ulcer size, and use of compression therapy. Each item is graded 0 (absent) to 3 (severe), yielding a maximum score of 30. The VCSS enables longitudinal tracking of disease progression and objective comparison of treatment outcomes [@eklof2004, @esvs2015]. It has also been shown to correlate with specific anatomical patterns of reflux, such as junctional involvement in patients with GSV insufficiency [@vemuri2023].